An interventional study of maCBT in Schizophrenia, Bipolar Disorder and Major Depression, sponsored by Nova Scotia Health Authority. Recruiting at 2 sites in Canada. Open to participants aged 9 Years to 21 Years. Per ClinicalTrials.gov, last updated 2025-05-14.
Sponsored by Nova Scotia Health Authority · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 193 studies in Schizophrenia with a site in Canada — 29 open to participants now, 37 under way, 1 of them phase 3. Schizophrenia · Canada.
Among the 193 studies in Schizophrenia with a site in Canada, this one is the 24th largest by planned enrollment of the 161 interventional ones that give a count, is one of 6 that started in 2014, is one of 83 with no phase, reaches primary completion later than 25 of the 36 other live ones, and was the 92nd registered.
3,574 studies on the registry are indexed under Schizophrenia; 494 are open to participants now.
Browse Schizophrenia studies →29 of the 193 studies in Schizophrenia with a site in Canada are open now. Recruiting first, the newest first:
Karuna Therapeutics, Inc., a Bristol Myers Squibb company · Sites in Canada, United States, Australia and 8 more countries
Ages 5–17
University of Toronto · Sites in Canada
Ages 18+
Douglas Mental Health University Institute · Sites in Canada
Ages 18–65
University of Ottawa · Sites in Canada
Ages 18–85
Ciusss de L'Est de l'Île de Montréal · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 333 Schizophrenia studies recruiting now, 63 (19%) set no upper age limit and 258 (77%) stop at 75 or younger; 42 take children under 18; 83 take healthy volunteers.
This study: 9 Years to 21 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
193 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 24 · Phase 3 34 · Phase 4 19
First in 1999; this study’s year is marked. 6 started in 2014.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 360 is above the median of 70 across 2,952 interventional studies indexed under Schizophrenia.
Median enrollment 77 across the 161 interventional studies, 109 across the 30 observational. Of the 135 that completed or were terminated, 37 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
53 of 193 have an industry lead sponsor. The 10 most frequent:
Nova Scotia Health Authority is the lead sponsor of 264 studies on the registry; 77 are open to participants now.
Nova Scotia Health Authority has 4 studies filed under Schizophrenia — fewer than ten, so there is no comparison to draw.
12 of the studies in Schizophrenia with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT01545999Centre for Addiction and Mental HealthPaired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia | 2026-12 |
| NCT05748990Centre for Addiction and Mental HealthDoes Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia | 2026-12-31 |
| NCT03788811diaMentis Inc.ERG Components in Schizophrenia and Bipolar Disorder Type I | 2026-12-31 |
| NCT05731414University of TorontoOutcomes From Remediation and Behavioural Intervention Techniques | 2027-01-31 |
| NCT06856161Fraser HealthA Novel Blood Test as a Biomarker in Mental Health | 2027-03-15 |
Add all 12 to your calendar (.ics) → With an account.
Among the 193 studies in Schizophrenia with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Severe mental illness such as schizophrenia and mood disorders typically develops at a young age and can cause life-long disability. Currently available treatments cannot cure severe mental illness. This makes it important to find ways to prevent severe mental illness in young people before it has a chance to develop. This research study will pilot a new preventive intervention for young people who are at high risk of developing severe mental illness. The investigators will target early preceding factors (the 'antecedents') to severe mental illness which includes anxiety, unusual hearing and visual experiences, the loss of previously acquired abilities, and sudden and unpredictable changes in mood. These antecedents strongly predict an increased risk of developing severe mental illness. They are often impairing and distressing to the individual but can be improved with self-management skills and parent training, and they are present in the individual years before the onset of severe mental illness which makes them an ideal target for early intervention. The goal is to intervene early enough in the young person's life that severe mental illness can be prevented, hopefully leading to a happy, healthy and productive adulthood. The investigators want to test the acceptability and short-term efficacy of this new preventive intervention.
The proposed research will test the acceptability and efficacy of an early preventive intervention for the antecedents to severe mental illness with the following hypotheses:
Design: the investigators are proposing to test a new preventive intervention for antecedent conditions for which most individuals would currently receive no intervention at all. Therefore, the best comparison for the proposed intervention is a group of individuals who do not differ from the intervention group at baseline but who are neither offered a specific intervention nor discouraged from seeking any treatment that they may normally receive. Such a non-intervention comparison group is best achieved using the recently-developed cohort-multiple randomized controlled design (cmRCT; Relton et al., 2010) In a cmRCT, eligible participants are identified within a cohort study, which follows up all participants and measures outcomes of interest. A proportion of eligible participants within the cohort is randomly selected and approached to be offered the intervention of interest, while the other eligible participants in the cohort are not so approached (i.e., controls). All participants continue to be followed up as part of the cohort irrespective of whether they accept the offered intervention or not. This enables a more realistic, fair and complete evaluation of the intervention effects. Those randomly selected to be offered maCBT will be approached, given full information about the planned intervention and asked to provide a separate written consent for the intervention study.
Intervention: Multimodal Antecedent-focussed Cognitive-behavioural Training (maCBT). This integrated model focuses on normalisation of the unusual experiences, their re-appraisal, exploring helpfulness of current coping, and developing a repertoire of strategies to decrease the impact of these experiences on the young person's life. The maCBT follows a manual describing obligatory and optional therapeutic elements, proposed list of modules, outline of a therapeutic session, and the integrated cognitive model. The model and techniques are adapted to an age range of 9 to 17 years, with more visual material and child friendly language options for the younger part of the age range (9-12) and more teen-relevant and interpersonal content options for the older part of the age range (13-17). The intervention will be delivered in 8 to 16 one-hour sessions in an individual format. Sessions will be initially weekly, and then spaced out to once every two weeks in the latter stages of the intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Multimodal Antecedent-focussed Cognitive-behavioural Training (maCBT). This integrated model focuses on normalisation of the unusual experiences, their re-appraisal, exploring helpfulness of current coping, and developing a repertoire of strategies to decrease the impact of these experiences on the young person's life. The maCBT follows a manual describing obligatory and optional therapeutic elements, proposed list of modules, outline of a therapeutic session, and the integrated cognitive model. The model and techniques are adapted to an age range of 9 to 17 years, with more visual material and child friendly language options for the younger part of the age range (9-12) and more teen-relevant and interpersonal content options for the older part of the age range (13-17). The intervention will be delivered in 8 to 16 one-hour sessions in an individual format. Sessions will be initially weekly, and then spaced out to once every two weeks in the latter stages of the intervention.
Behavioral: maCBT
Naturalistic comparison arm: No intervention offered, no intervention prohibited.
Multimodal Antecedent-focussed Cognitive-behavioural Training (maCBT) is an individual manualized psychological intervention. It follows an integrated model focussed on normalisation of the unusual experiences, their re-appraisal, exploring helpfulness of current coping, and developing a repertoire of strategies to decrease the impact of these experiences on the young person's life. The maCBT follows a manual describing obligatory and optional therapeutic elements, proposed list of modules, outline of a therapeutic session, and the integrated cognitive model. The intervention will be delivered in 8 to 16 one-hour sessions in an individual format. Sessions will be initially weekly, and then spaced out to once every two weeks in the latter stages of the intervention.
Also known as: Multimodal Antecedent-focussed Cognitive-behavioural Training
Early antecedents to severe mental illness
Presence of any one (or more) of four early antecedents that may indicate risk for developing severe mental illness (psychotic-like experiences, basic symptoms, anxiety and affective lability). psychotic-like experiences - presence of one or more definite clinician-confirmed psychotic symptoms on Funny Feelings instrument. basic symptoms = presence of COGDIS (Cognitive Disturbances) or COPER (Cognitive-perceptive basic symptoms) high risk profile on the Schizophrenia Proneness Instrument - Child and Youth version (SPI-CY) anxiety = diagnosis of an anxiety disorder on K-SADS (Kiddie-Schedule for Affective Disorders and Schizophrenia) interview or score above the high specificity cutoff (30 or higher) on the SCARED (Screen for Child Anxiety Related Disorders) questionnaire (self or parent report) affective lability = score of 1 standard deviation or more above general population on the affective lability scales (self- or parent report)
Time frame: 4-6 months after the end of the intervention
Severe mental illness (long-term outcome)
Diagnosis of major mood (major depressive disorder, bipolar disorder) or psychotic disorder (schizophrenia, schizoaffective, schizophreniform, or delusional disorder)on K-SADS or SCID (Structured Clinical Interview for DSM) diagnostic interviews on any follow-up visit.
Time frame: Annual follow-ups over 3, 5, 7 and 10 years
Distress associated with unusual experiences
Distress ratings of the Funny Feelings questionnaire.
Time frame: 4-6 months, 1, 2, 3, and 5 years post intervention
Functioning
General, social and role functioning scales; employment status.
Time frame: 4-6 months, 1, 2, 3, 5 , 7 and 10 years post intervention.
psychotic-like experiences
presence of one or more definite clinician-confirmed psychotic symptoms on the Funny Feelings instrument
Time frame: 4-6 months, 1, 2, 3, and 5 years post intervention
basic symptoms
presence of COGDIS (Cognitive Disturbances) or COPER (Cognitive-perceptive basic symptoms) high risk profile on the Schizophrenia Proneness Instrument - Child and Youth version (SPI-CY)
Time frame: 4-6 months, 1, 2, 3, and 5 years post intervention
Anxiety
diagnosis of an anxiety disorder on K-SADS (Kiddie-Schedule for Affective Disorders and Schizophrenia) interview or score above the high specificity cutoff (30 or higher) on the SCARED (Screen for Child Anxiety Related Disorders) questionnaire (self or parent report)
Time frame: 4-6 months, 1, 2, 3, and 5 years post intervention
Affective lability - continuous
Total score on the Affective Lability Scales. Continuous.
Time frame: 4-6 months, 1, 2, 3, and 5 years post intervention
Affective lability
Score of 1 standard deviation or more above general population on the affective lability scales (self- or parent report)
Time frame: 4-6 months, 1, 2, 3, and 5 years post intervention
Anxiety - continuous
Total score on the SCARED (Screen for Child Anxiety Related Disorders) questionnaire.
Time frame: 4-6 months, 1, 2, 3, and 5 years post intervention
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2014 (actual). Primary completion is estimated for Jun 2027, 159 months after the start.
Of 763 non-industry interventional studies with no phase under Schizophrenia, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 56. This study's planned 159 months is above that.
Counting every sponsor, half of 776 studies reached it within 32 months; a quarter within 16 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nova Scotia Health Authority →